文献速递淋巴瘤

成人伴伯基特淋巴瘤特征的高级别B细胞淋巴瘤:基因组特征与潜在治疗靶点

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
PubMed 文献 · Blood · 2017-08-11

成人伯基特淋巴瘤(BL)及伴BL基因特征的高级别B细胞淋巴瘤(成人分子定义BL,mBL)侵袭性强、预后差。高分辨率结构与功能基因组分析显示MYC-ARF-p53轴为主要失调通路,成人mBL较儿童mBL有独特或更频繁的基因组异常,部分病例伴BCL2易位和突变,50%成人mBL可见MIR17HG增益/扩增,体外研究提示miR-17~92参与BCR信号组成性激活及对依鲁替尼的敏感性。

要点

  • 成人mBL较儿童mBL更常见del13q14、del17p、gain8q24和gain18q21,但共享常见突变基因。
  • 成人mBL中BCR→PI3K通路基因(TCF3、ID3)突变率无年龄差异,慢性BCR→NF-κB信号效应基因与成人mBL相关。
  • 部分成人mBL伴BCL2易位和突变、BCL2 mRNA及蛋白表达升高,突变谱类似mBL,可能源于同时获得BCL2和MYC易位和/或KMT2D突变的肿瘤前体。

核心结论

  • 整合分析识别出受拷贝数变异和突变影响的相互关联基因网络,导致p53通路破坏及BCR→PI3K或NF-κB激活,可在体内利用小分子抑制剂进一步开发用于成人mBL的有效治疗。

研究设计与样本

  • 对成人伯基特淋巴瘤(BL)和伴BL基因特征的高级别B细胞淋巴瘤(成人分子定义BL,mBL)进行高分辨率结构与功能基因组分析,并开展体外研究。

主要发现

  • MYC-ARF-p53轴为成人mBL主要失调通路。
  • 成人mBL较儿童mBL有独特或更频繁的基因组异常:del13q14、del17p、gain8q24和gain18q21,但共享常见突变基因。
  • 促进 tonic BCR→PI3K 通路的基因(TCF3和ID3)突变率无年龄差异,而慢性BCR→NF-κB信号效应基因与成人mBL相关。
  • 部分成人mBL伴BCL2易位和突变、BCL2 mRNA及蛋白表达升高,突变谱类似mBL,可能源于同时获得BCL2和MYC易位和/或KMT2D(MLL2)突变的肿瘤前体。
  • 50%成人mBL可见MIR17HG及其旁系同源位点增益/扩增;体外研究提示miR-17~92参与BCR信号组成性激活及对依鲁替尼的敏感性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The adult high-grade B-cell lymphomas sharing molecular features with Burkitt lymphoma (BL) are highly aggressive lymphomas with poor clinical outcome. High-resolution structural and functional genomic analysis of adult Burkitt lymphoma (BL) and high-grade B-cell lymphoma with BL gene signature (adult-molecularly defined BL [mBL]) revealed the MYC-ARF-p53 axis as the primary deregulated pathway. Adult-mBL had either unique or more frequent genomic aberrations (del13q14, del17p, gain8q24, and gain18q21) compared with pediatric-mBL, but shared commonly mutated genes. Mutations in genes promoting the tonic B-cell receptor (BCR)→PI3K pathway (TCF3 and ID3) did not differ by age, whereas effectors of chronic BCR→NF-κB signaling were associated with adult-mBL. A subset of adult-mBL had BCL2 translocation and mutation and elevated BCL2 mRNA and protein expression, but had a mutation profile similar to mBL. These double-hit lymphomas may have arisen from a tumor precursor that acquired both BCL2 and MYC translocations and/or KMT2D (MLL2) mutation. Gain/amplification of MIR17HG and its paralogue loci was observed in 50% of adult-mBL. In vitro studies suggested miR-17∼92's role in constitutive activation of BCR signaling and sensitivity to ibrutinib. Overall integrative analysis identified an interrelated gene network affected by copy number and mutation, leading to disruption of the p53 pathway and the BCR→PI3K or NF-κB activation, which can be further exploited in vivo by small-molecule inhibitors for effective therapy in adult-mBL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Bouska A, Bi C, Lone W, et al. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. Blood. 2017. PMID: 28801451. doi:10.1182/blood-2017-02-767335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。